BRUSSELS, March 15, 2006-Solvay Pharmaceuticals today announces the signing of additional agreements for important geographical expansions to one of its top selling products AndroGel® with the pharmaceutical company Besins International. AndroGel® is market leader in the segment of Testosterone Replacement Therapy (TRT) and one of Solvay’s solid performers; in 2005 Solvay sales exceeded EUR 235 million Euro in the USA, Canada and Germany.
